Drugs / NNC0114-0000-0005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01208506 | Sep 2010 → Feb 2012 | rheumatoid arthritis | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC0114-0000-0005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01208506 ↗ |
| Route | Intravenous | “A single dose of NNC0114-0000-0005 administered i.v. (into the vein) in healthy subjects.” NCT01208506 ↗ |